A review and update on the molecular basis of pathogenesis of Sorsby fundus dystrophy

Advances in Experimental Medicine and Biology

Volumn 723, Issue , 2012, Pages 261-267

  Stöhr, Heidi ^a   Anand Apte, Bela ^b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

AMD; Angiogenesis; Bruch's Membrane; Choroidal Neovascularization; Extracellular Matrix; Sorsby Fundus Dystrophy; TIMP3; VEGF

Indexed keywords

TISSUE INHIBITOR OF METALLOPROTEINASE 3; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; AUTOSOMAL DOMINANT DISORDER; CARBOXY TERMINAL SEQUENCE; CONFERENCE PAPER; DISEASE MODEL; GENE; GENE IDENTIFICATION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; MOLECULAR MECHANICS; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA DEGENERATION; SORSBY FUNDUS DYSTROPHY; SUBRETINAL NEOVASCULARIZATION; TIMP3 GENE; VISUAL DISORDER;

ANIMALS; BRUCH MEMBRANE; CHOROIDAL NEOVASCULARIZATION; FUNDUS OCULI; HUMANS; MACULAR DEGENERATION; RETINAL DYSTROPHIES; TISSUE INHIBITOR OF METALLOPROTEINASE-3;

EID: 84855948699     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-0631-0_34     Document Type: Conference Paper

References (38)

1. Arris CE, Bevitt DJ, Mohamed J et al (2003) Expression of mutant and wild-type TIMP3 in primary gingival fi broblasts from Sorsby's fundus dystrophy patients. Biochim Biophys Acta 1638: 20-28 (Pubitemid 36577367)
2. Barbazetto IA, Hayashi M, Klais CM et al (2005) A novel TIMP3 mutation associated with Sorsby fundus dystrophy. Arch Ophthalmol 123: 542-543 (Pubitemid 40489928)
3. Brew K, Nagase H (2010) The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim Biophys Acta 1803: 55-71
4. Capon MRC, Marshall J, Krafft JI et al (1989) Sorsby's fundus dystrophy: a light and electron microscopic study. Ophthalmology 96: 1769-1777 (Pubitemid 20013635)
5. Chen W, Stambolian D, Edwards AO et al (2010) Genetic variants near TIMP3 and high-density lipoprotein-associated loci infl uence susceptibility to age-related macular degeneration. Proc Natl Acad Sci USA 107: 7401-7406
6. Chong NH, Alexander RA, Gin T et al (2000) TIMP-3, collagen, and elastin immunohistochemistry and histopathology of Sorsby's fundus dystrophy. Invest Ophthalmol Vis Sci 41: 898-902 (Pubitemid 30158906)
7. Clarke M, Mitchell KW, Goodship J et al (2001) Clinical features of a novel TIMP-3 mutation causing Sorsby's fundus dystrophy: implications for disease mechanism. Br J Ophthalmol 85: 1429-1431 (Pubitemid 34032907)
8. Ebrahem Q, Qi J, Sugimoto M et al. (2011) Increased neovascularization in mice lacking tissue inhibitor of metalloproteinases-3. Invest Ophthalmol Vis Sci 52: 6117-6123
9. Fariss RN, Apte SS, Luthert PJ et al (1998) Accumulation of tissue inhibitor of metalloproteinases- 3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa. Br J Ophthalmol 82: 1329-1334 (Pubitemid 28524133)
10. Fedak PW, Smookler DS, Kassiri Z et al (2004) TIMP-3 defi ciency leads to dilated cardiomyopathy. Circulation 110: 2401-2409 (Pubitemid 39407346)
11. Felbor U, Stöhr H, Amann T et al (1995) A novel Ser156Cys mutation in the tissue inhibitor of metalloproteinases-3 (TIMP3) in Sorsby's fundus dystrophy with unusual clinical features. Hum Mol Genet 4: 2415-2416
12. Felbor U, Benkwitz C, Litt M et al (1997) A founder mutation in TIMP3, Ser181Cys, presents with variable expressivity of Sorsby fundus dystrophy. Arch Ophthalmol 115: 1569-1571 (Pubitemid 28007140)
13. Fogarasi M, Janssen A, Weber BH et al (2008) Molecular dissection of TIMP3 mutation S156C associated with Sorsby fundus dystrophy. Matrix Biol 27: 381-292
14. Fu L, Garland D, Yang Z et al (2007) The R345W mutation in EFEMP1 is pathogenic and causes AMD-like deposits in mice. Hum Mol Genet 16: 2411-2422 (Pubitemid 47500628)
15. Jacobson SG, Cideciyan AV, Regunath G et al (1995) Night blindness in Sorsby's fundus dystrophy reversed by vitamin A. Nat Genet 11: 27-32
16. Jacobson SG, Cideciyan AV, Bennett J et al (2002) Novel mutation in the TIMP3 gene causes Sorsby fundus dystrophy. Arch Ophthalmol 120: 376-379 (Pubitemid 34250061)
17. Janssen A, Hoellenriegel J, Fogarasi M et al (2008) Abnormal vessel formation in the choroid of mice lacking tissue inhibitor of metalloprotease-3. Invest Ophthalmol Vis Sci 49: 2812-2822
18. Kamei M, Hollyfi eld JG (1999). Invest Ophthalmol Vis Sci 40: 2367-2375
19. Klenotic PA, Munier FL, Marmorstein LY et al (2004) Tissue inhibitor of metalloproteinases-3 (TIMP-3) is a binding partner of epithelial growth factor-containing fi bulin-like extracellular matrix protein 1 (EFEMP1). Implications for macular degenerations. J Biol Chem 279: 30469-30473 (Pubitemid 38937976)
20. Langton KP, McKie N, Curtis A et al (2000) A novel tissue inhibitor of metalloproteinases-3 mutation reveals a common molecular phenotype in Sorsby's fundus dystrophy. J Biol Chem 275: 27027-27031
21. Langton KP, McKie N, Smith BM et al (2005) Sorsby's fundus dystrophy mutations impair turnover of TIMP-3 by retinal pigment epithelial cells. Hum Mol Genet 14: 3579-3586 (Pubitemid 41754659)
22. Leco KJ, Waterhouse P, Sanchez OH et al (2001) Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3). J Clin Invest 108: 817-829 (Pubitemid 32884192)
23. Lin RJ, Blumenkranz MS, Binkley J et al (2006) A novel His158Arg mutation in TIMP3 causes a late-onset form of Sorsby fundus dystrophy. Am J Ophthalmol 142: 839-848
24. Mahmoodi M, Sahebjam S, Smookler D et al (2005) Links Lack of tissue inhibitor of metalloproteinases- 3 results in an enhanced infl ammatory response in antigen-induced arthritis. Am J Pathol 166: 1733-1740 (Pubitemid 40734396)
25. Mohammed FF, Smookler DS, Taylor SE et al (2004) Abnormal TNF activity in Timp3 ?/? mice leads to chronic hepatic infl ammation and failure of liver regeneration. Nat Genet 36: 969-977 (Pubitemid 39167493)
26. Polkinghorne PJ, Capon MRC, Berninger T et al (1989) Sorsby's fundus dystrophy: a clinical study. Ophthalmology 96: 1763-1768 (Pubitemid 20013634)
27. Qi JH, Dai G, Luthert P et al (2009) S156C mutation in tissue inhibitor of metalloproteinases-3 induces increased angiogenesis. J Biol Chem 284: 19927-19936
28. Qi JH, Ebrahem Q, Moore N et al (2003) A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor 2. Nat Med 9: 407-415 (Pubitemid 36460074)
29. Qi JH, Ebrahem Q, Yeow K et al (2002) Expression of Sorsby's fundus dystrophy mutations in human retinal pigment epithelial cells reduces matrix metalloproteinase inhibition and may promote angiogenesis. J Biol Chem 277: 13394-13400 (Pubitemid 34967932)
30. Saihan Z, Li Z, Rice J et al (2009) Clinical and biochemical effects of the E139K missense mutation in the TIMP3 gene, associated with Sorsby fundus dystrophy. Mol Vis 15: 1218-1230
31. Sivaprasad S. Webster AR, Egan CA et al (2008) Clinical Course and Treatment Outcomes of Sorsby Fundus Dystrophy. Am J Ophthalmol 146: 228-234
32. Soboleva G, Geis B, Schrewe H et al (2003) Sorsby fundus dystrophy mutation Timp3(S156C) affects the morphological and biochemical phenotype but not metalloproteinase homeostasis. J Cell Physiol 197: 149-156 (Pubitemid 37486237)
33. Sorsby A, Mason MEJ, Gardner N (1949) A fundus dystrophy with unusual features (late onset and dominant inheritance of a central retinal lesion showing oedema, haemorrhage and exudates developing into generalised choroidal atrophy with massive pigment proliferation). Br J Ophthalmol 33: 67-97
34. Tabata Y, Isashiki Y, Kamimura K et al (1998) A novel splice site mutation in the tissue inhibitor of the metalloproteinases-3 gene in Sorsby's fundus dystrophy with unusual clinical features. Hum Genet 103: 179-182 (Pubitemid 28444656)
35. Troeberg L, Fushimi K, Khokha R et al (2008) Calcium pentosan polysulfate is a multifaceted exosite inhibitor of aggrecanases. FASEB J 22: 3515-3524
36. Weber B, Vogt G, Pruett RC et al (1994) Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy. Nat Genet 8: 352-356 (Pubitemid 24375600)
37. Weber BH, Lin B, White K et al (2002) A mouse model for Sorsby fundus dystrophy. Invest Ophthalmol Vis Sci 43: 2732-2740 (Pubitemid 34809467)
38. Yeow KM, Kishnani NS, Hutton M et al (2002) Sorsby's fundus dystrophy tissue inhibitor of metalloproteinases-3 (TIMP-3) mutants have unimpaired matrix metalloproteinase inhibitory activities, but affect cell adhesion to the extracellular matrix. Matrix Biol 21: 75-88 (Pubitemid 34100825)